PortfoliosLab logoPortfoliosLab logo
GDOC vs. XPH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

GDOC vs. XPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Goldman Sachs Future Health Care Equity ETF (GDOC) and SPDR S&P Pharmaceuticals ETF (XPH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GDOC vs. XPH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GDOC
Goldman Sachs Future Health Care Equity ETF
-8.12%10.74%-1.66%4.60%-17.12%-2.77%
XPH
SPDR S&P Pharmaceuticals ETF
-3.32%31.60%4.94%2.97%-9.83%-8.94%

Returns By Period

In the year-to-date period, GDOC achieves a -8.12% return, which is significantly lower than XPH's -3.32% return.


GDOC

1D
2.76%
1M
-5.94%
YTD
-8.12%
6M
2.88%
1Y
1.53%
3Y*
0.66%
5Y*
10Y*

XPH

1D
5.32%
1M
-5.56%
YTD
-3.32%
6M
13.19%
1Y
24.45%
3Y*
11.04%
5Y*
2.79%
10Y*
3.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


GDOC vs. XPH - Expense Ratio Comparison

GDOC has a 0.75% expense ratio, which is higher than XPH's 0.35% expense ratio.


Return for Risk

GDOC vs. XPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GDOC
GDOC Risk / Return Rank: 1414
Overall Rank
GDOC Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
GDOC Sortino Ratio Rank: 1313
Sortino Ratio Rank
GDOC Omega Ratio Rank: 1313
Omega Ratio Rank
GDOC Calmar Ratio Rank: 1414
Calmar Ratio Rank
GDOC Martin Ratio Rank: 1414
Martin Ratio Rank

XPH
XPH Risk / Return Rank: 5959
Overall Rank
XPH Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 5959
Sortino Ratio Rank
XPH Omega Ratio Rank: 5050
Omega Ratio Rank
XPH Calmar Ratio Rank: 7171
Calmar Ratio Rank
XPH Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GDOC vs. XPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Goldman Sachs Future Health Care Equity ETF (GDOC) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GDOCXPHDifference

Sharpe ratio

Return per unit of total volatility

0.08

1.00

-0.92

Sortino ratio

Return per unit of downside risk

0.25

1.47

-1.22

Omega ratio

Gain probability vs. loss probability

1.03

1.19

-0.16

Calmar ratio

Return relative to maximum drawdown

0.10

1.77

-1.66

Martin ratio

Return relative to average drawdown

0.31

5.52

-5.21

GDOC vs. XPH - Sharpe Ratio Comparison

The current GDOC Sharpe Ratio is 0.08, which is lower than the XPH Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of GDOC and XPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


GDOCXPHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.08

1.00

-0.92

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.20

0.38

-0.58

Correlation

The correlation between GDOC and XPH is 0.76, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

GDOC vs. XPH - Dividend Comparison

GDOC's dividend yield for the trailing twelve months is around 0.35%, less than XPH's 0.69% yield.


TTM20252024202320222021202020192018201720162015
GDOC
Goldman Sachs Future Health Care Equity ETF
0.35%0.32%0.02%0.55%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XPH
SPDR S&P Pharmaceuticals ETF
0.69%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Drawdowns

GDOC vs. XPH - Drawdown Comparison

The maximum GDOC drawdown since its inception was -31.01%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for GDOC and XPH.


Loading graphics...

Drawdown Indicators


GDOCXPHDifference

Max Drawdown

Largest peak-to-trough decline

-31.01%

-48.03%

+17.02%

Max Drawdown (1Y)

Largest decline over 1 year

-14.57%

-13.15%

-1.42%

Max Drawdown (5Y)

Largest decline over 5 years

-31.63%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

Current Drawdown

Current decline from peak

-15.86%

-7.29%

-8.57%

Average Drawdown

Average peak-to-trough decline

-15.90%

-17.37%

+1.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.96%

5.23%

-0.27%

Volatility

GDOC vs. XPH - Volatility Comparison

The current volatility for Goldman Sachs Future Health Care Equity ETF (GDOC) is 6.04%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 9.49%. This indicates that GDOC experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


GDOCXPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.04%

9.49%

-3.45%

Volatility (6M)

Calculated over the trailing 6-month period

11.22%

16.38%

-5.16%

Volatility (1Y)

Calculated over the trailing 1-year period

18.63%

24.72%

-6.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.83%

20.56%

-1.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.83%

22.22%

-3.39%